journal article·2022-03Open access

Hepatic Suppression of Mitochondrial Complex II Assembly Drives Systemic Metabolic Benefits

Xueqiang Wang, Weiqiang Lv, Jie Xu, Adi Zheng, Mengqi Zeng, Ke Cao, Xun Wang, Yuting Cui, Hao Li, Meng Yang, Yongping Shao, Fang Zhang, Xuan Zou, Jiangang Long, Zhihui Feng, Jiankang Liu

Advanced Science· Volume 9· Issue 9

Abstract

Abstract Alternate day fasting (ADF), the most popular form of caloric restriction, has shown to improve metabolic health in preclinical subjects, while intrinsic network underpinning the process remains unclear. Here, it is found that liver undergoes dramatic metabolic reprogramming during ADF, accompanied surprisingly with unique complex II dysfunction attributing to suspended complex II assembly via suppressing SDHAF4, a recently identified assembly factor. Despite moderate mitochondrial complex II dysfunction, hepatic Sdhaf4 knockout mice present intriguingly improved glucose tolerance and systemic insulin sensitivity, consistent with mice after ADF intervention. Mechanistically, it is found that hepatocytes activate arginine‐nitric oxide (NO) biosynthesis axle in response to complex II and citric acid cycle dysfunction, the release of NO from liver can target muscle and adipocytes in addition to its autocrine action for enhanced insulin sensitivity. These results highlight the pivotal role of liver in ADF‐associated systemic benefits, and suggest that targeting hepatic complex II assembly can be an intriguing strategy against metabolic disorders.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Dietary Effects on Health · Circadian rhythm and melatonin · Diet and metabolism studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Center for Mitochondrial Biology and Medicine The Key Laboratory of Biomedical Information Engineering of Ministry of Education School of Life Science and Technology Xi'an Jiaotong University Xi'an Shaanxi 710049 China

Frontier Institute of Science and Technology Xi'an Jiaotong University Xi'an Shaanxi 710049 China

Department of Ophthalmology Shanghai General Hospital Shanghai Jiao Tong University School of Medicine Xi'an Shanghai 200240 China

National Clinical Research Center for Eye Diseases Shanghai 200240 China

National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an Shannxi 710004 China

Shaanxi Provincial Clinical Research Center for Hepatic & Splenic Diseases The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an Shannxi 710004 China

University of Health and Rehabilitation Sciences Qingdao Shandong 266071 China

Funding

National Natural Science Foundation of China · National Key Research and Development Program of China

References (54)

Show source-provided references
1. 10.1111/dom.1408010.1111/dom.14080 ↗
2. 10.1007/s13238-013-0002-310.1007/s13238-013-0002-3 ↗
3. 10.1016/j.cmet.2017.08.00410.1016/j.cmet.2017.08.004 ↗
4. 10.1016/j.cmet.2018.08.01110.1016/j.cmet.2018.08.011 ↗
5. 10.1016/j.cmet.2012.04.01910.1016/j.cmet.2012.04.019 ↗
6. 10.1016/j.cmet.2016.06.00110.1016/j.cmet.2016.06.001 ↗
7. 10.1016/j.cmet.2017.06.00710.1016/j.cmet.2017.06.007 ↗
8. 10.1016/j.cmet.2018.08.00410.1016/j.cmet.2018.08.004 ↗
9. 10.1093/ajcn/86.1.710.1093/ajcn/86.1.7 ↗
10. 10.1016/j.jnutbio.2020.10840310.1016/j.jnutbio.2020.108403 ↗
11. 10.1016/j.lfs.2013.06.00710.1016/j.lfs.2013.06.007 ↗
12. 10.3945/ajcn.2009.2838010.3945/ajcn.2009.28380 ↗
13. 10.1016/j.cmet.2019.07.01610.1016/j.cmet.2019.07.016 ↗
14. 10.1038/s41574-019-0270-y10.1038/s41574-019-0270-y ↗
15. 10.5483/BMBRep.2013.46.12.24810.5483/BMBRep.2013.46.12.248 ↗
16. 10.1074/jbc.RA120.01438110.1074/jbc.RA120.014381 ↗
17. 10.1016/j.redox.2017.01.01210.1016/j.redox.2017.01.012 ↗
18. 10.1038/emm.2015.12210.1038/emm.2015.122 ↗
19. 10.1002/j.2040-4603.2014.tb00548.x10.1002/j.2040-4603.2014.tb00548.x ↗
20. 10.1038/s41467-018-06083-710.1038/s41467-018-06083-7 ↗
21. 10.1016/S0925-4439(97)00035-510.1016/S0925-4439(97)00035-5 ↗
22. 10.1111/jpn.1254610.1111/jpn.12546 ↗
23. 10.1111/jpn.1202210.1111/jpn.12022 ↗
24. 10.1016/j.cell.2005.05.02510.1016/j.cell.2005.05.025 ↗
25. 10.1073/pnas.200739111710.1073/pnas.2007391117 ↗
26. 10.1016/j.cmet.2014.05.01210.1016/j.cmet.2014.05.012 ↗
27. 10.3389/fendo.2018.0080210.3389/fendo.2018.00802 ↗
28. 10.1016/j.celrep.2017.04.07110.1016/j.celrep.2017.04.071 ↗
29. Haines R. J. · Int. J. Biochem. Mol. Biol. · 2011 · 2 · 8
30. 10.1038/nm.254410.1038/nm.2544 ↗
31. 10.1126/scisignal.abb249010.1126/scisignal.abb2490 ↗
32. 10.1002/oby.2256410.1002/oby.22564 ↗
33. 10.1007/978-3-030-45328-2_210.1007/978-3-030-45328-2_2 ↗
34. 10.1111/febs.1548210.1111/febs.15482 ↗
35. 10.1016/j.freeradbiomed.2017.06.01310.1016/j.freeradbiomed.2017.06.013 ↗
36. 10.1007/s11357-020-00187-z10.1007/s11357-020-00187-z ↗
37. 10.1016/j.mad.2017.02.00410.1016/j.mad.2017.02.004 ↗
38. 10.1016/j.metabol.2020.15433610.1016/j.metabol.2020.154336 ↗
39. 10.1016/j.mito.2020.08.00310.1016/j.mito.2020.08.003 ↗
40. 10.1016/j.mito.2020.07.00710.1016/j.mito.2020.07.007 ↗
41. 10.1016/j.bbabio.2012.09.00310.1016/j.bbabio.2012.09.003 ↗
42. 10.1104/pp.18.0032010.1104/pp.18.00320 ↗
43. 10.1007/s00439-015-1568-z10.1007/s00439-015-1568-z ↗
44. 10.1136/jmedgenet-2012-10114610.1136/jmedgenet-2012-101146 ↗
45. 10.1016/S1470-2045(10)70007-310.1016/S1470-2045(10)70007-3 ↗
46. 10.1016/j.cmet.2019.01.01810.1016/j.cmet.2019.01.018 ↗
47. Chen X. · Exp. Ther. Med. · 2017 · 14 · 5305
48. 10.3390/ijms22211173810.3390/ijms222111738 ↗
49. 10.3390/biomedicines808027710.3390/biomedicines8080277 ↗
50. 10.1113/EP08810910.1113/EP088109 ↗
51. 10.1016/j.freeradbiomed.2014.05.01610.1016/j.freeradbiomed.2014.05.016 ↗
52. 10.1002/advs.20200450710.1002/advs.202004507 ↗
53. 10.1016/j.freeradbiomed.2011.03.00110.1016/j.freeradbiomed.2011.03.001 ↗
54. 10.1021/acs.analchem.6b0222210.1021/acs.analchem.6b02222 ↗